CFAR Co-Director and Scientific Working Group leader in AIDS-Associated Infections and Malignancies (AAIMs) is featured in an NPR article and interview on KUOW 94.9FM.
UW News published an article detailing some of Dr. Kim Woodrow's new work, a method of providing contraception and prevent HIV transmission by using electrically spun cloth with nanometer-sized fibers that can dissolve to release drugs.
Scientists used genetic sequencing to discover that the vaccine used in the RV144 HIV vaccine trial, involving 16,000 men and women in Thailand, did offer some protection against certain HIV viruses. The results were published Sept. 10 in the online edition of Nature.
The U.S. Food and Drug Administration decided today, July 16, to approve the use of an HIV treatment drug for reducing the risk of acquiring HIV.
By Keegan Hamilton
Now, as HIV/AIDS researchers worldwide seem to be moving closer to a possible HIV vaccine, Hu has received a vote of confidence from the Bill & Melinda Gates Foundation for his contributions to the field.
By Pam Belluck; posted 10/03/2011; 5:05 pm.
From PC Magazine; Leslie Horn; 9/19/2011; 10:42am EST
Revalesio, a pioneering biotechnology company based in Tacoma, recently signed an 18-month contract with the Katze lab at the UW to bring hope to sufferers of influenza, HIV and hepatitis C.